Novel Curcumin Analogue L6H4 in Treating Liver Fibrosis and Type 2 Diabetes

MLA

Ma J, et al. “Novel Curcumin Analogue L6H4 in Treating Liver Fibrosis and Type 2 Diabetes.” Diabetes, Metabolic Syndrome and Obesity, vol. ume 16, Aug. 2023, pp. 2639–50. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.6a94d01f5cc0444aa0cd5026d59f8a8f&authtype=sso&custid=ns315887.

APA

Ma J, Vaishnani DK, Mansi, Zeng J, Xie Z, Jin X, Zhang H, Wut Yi Hla K, & Ying F. (2023). Novel Curcumin Analogue L6H4 in Treating Liver Fibrosis and Type 2 Diabetes. Diabetes, Metabolic Syndrome and Obesity, ume 16, 2639–2650.

Chicago

Ma J, Vaishnani DK, Mansi, Zeng J, Xie Z, Jin X, Zhang H, Wut Yi Hla K, and Ying F. 2023. “Novel Curcumin Analogue L6H4 in Treating Liver Fibrosis and Type 2 Diabetes.” Diabetes, Metabolic Syndrome and Obesity ume 16 (August): 2639–50. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.6a94d01f5cc0444aa0cd5026d59f8a8f&authtype=sso&custid=ns315887.